Navigation Links
The New York Times Bestselling Thriller, WIRED, Now Being Given Away on Amazon (Unlimited Copies)
Date:8/23/2013

New York, New York (PRWEB) August 23, 2013

The riveting biotech thriller, WIRED, by Douglas E. Richards, a New York Times and USA Today bestseller, was Amazon's #1 novel in two major categories—science fiction and technothrillers—an unprecedented achievement. Now, to celebrate the launch of Richards's new thriller, THE CURE, the eBook version of WIRED will be free on Amazon on August 23rd, 24th, and 25th. LINK TO FREE COPY

THE CURE will be launched as a hardcover and eBook on September 17th by Tor/Forge and can be preordered now. In THE CURE, Erin Palmer suffers through a devastating encounter with a psychopath as a young girl. Now a grad student and scientist , she’s devoting her life to studying these monsters. When her research catches the attention of Hugh Raborn, a brilliant neuroscientist who claims to have isolated the genes responsible for psychopathic behavior, Erin realizes it may be possible to reverse this condition, restoring souls to psychopaths. But to do so, she’ll not only have to operate outside of the law but violate her most cherished ethical principles.

Psychopaths seem to be at epidemic levels. THE CURE provides an eye-opening look at what is known about psychopathy within an intriguing, explosive, roller-coaster-ride of a novel that will keep both thriller fans and science fiction fans reading deep into the night.

“Richards is a tremendous new talent. The Cure is an extraordinarily good novel that will keep you riveted . . . and thinking.”
—Stephen Coonts, 17-time New York Times bestselling author of Pirate Alley

“The Cure will keep you turning the pages all night long.”
—Douglas Preston, #1 New York Times bestselling author of Impact

The Cure will be released on Sept 17th and will be available everywhere books are sold.

LINK TO FREE COPY OF WIRED

Read the full story at http://www.prweb.com/releases/2013/8/prweb11037973.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Sanovas CEO Larry Gerrans Featured at BayBios Fundraising in Troubled Times
2. Probiotic Action Announces Further Exploration of Probiotics for Acne with New Information from the LA Times
3. New Research Suggests Probiotics May Lower Cholesterol, Probiotic Action Reports with Insight from the New York Times
4. Riveting NY Times Bestselling Biotech Thriller, WIRED, Now Only $5.95 for Kindle Owners
5. The #1 Science Fiction Novel of 2011 (and NY Times Bestseller) Now Only $5.95
6. National Defense Industrial Association's (NDIA) 2012 Biosurveillance Conference To Feature Keynote Speaker Laurie Garrett, Pulitzer Prize Winner and Bestselling Author
7. Riveting Biotechnology Novel, WIRED, Becomes the #1 Technothriller on Amazon
8. Riveting Biotechnology Novel, WIRED, Becomes the #1 Technothriller on Amazon
9. Riveting Biotechnology Novel, WIRED, Becomes the #1 Technothriller on Amazon
10. Riveting Biotechnology Novel, WIRED, Becomes the #1 Technothriller on Amazon
11. Breast Cancer Vaccine Being Developed by Generex Subsidiary Antigen Express to be Featured on Bloomberg Television Today
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... and SAN FRANCISCO , Feb. ... regenerative medicine company, and Beyond Type 1, a not-for-profit ... 1 diabetes, today announced a grant from Beyond Type ... cure for type 1 and other insulin-requiring diabetes.  ... been developing innovative stem cell-derived cell replacement therapies with ...
(Date:2/22/2017)...  PrimeVax Immuno-Oncology, Inc. announced today its CEO, ... Biocom Global Life Science Partnering Conference.  The presentation will ... the Torrey Pines Lodge, in San Diego.  ... who have chosen our company, amongst numerous others, to ... and clinical researchers," said Mr. Chen. "In contrast to ...
(Date:2/22/2017)... ... February 22, 2017 , ... LabRoots , the leading provider of educational ... is pleased to announce the launch of a new scholarship for young scientists seeking ... This merit-based scholarship is open to all high school seniors, 17 years or older; ...
(Date:2/22/2017)... , ... February 22, 2017 , ... ... the addition of Tom Perkins as European director. Operating from Pennside’s Zurich headquarters, ... Pennside. , Perkins joins Pennside after more than a decade with leading ...
Breaking Biology Technology:
(Date:1/31/2017)... Mass. , Jan. 31, 2017  Spero ... novel therapies for the treatment of bacterial infections, ... set of antibacterial candidates from Pro Bono Bio ... increased prevalence of multi-drug resistant forms of Gram-negative ... Cantab Anti Infectives Ltd, a PBB group company. ...
(Date:1/26/2017)... , Jan. 26, 2017  Acuity Market ... for Biometrics and Digital Identity".  Acuity characterizes 2017 ... identity when increased adoption reflects a new understanding ... "Biometrics and digital identity are often ... Maxine Most , Principal of Acuity Market ...
(Date:1/24/2017)... 2017  It sounds simple and harmless—an electronic ... vital signs and alerts parents on their smart ... level drops. But pediatric experts argue that such ... no evidence of medical benefits, especially to healthy ... to parents of healthy babies, promising peace of ...
Breaking Biology News(10 mins):